4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
PeptiDream Inc. (4587) operates in the Biotechnology industry and is headquartered in Kawasaki, Japan with about 745 employees. Its market capitalization is roughly JPY 127 billion. In the fiscal year ended 2025-12-31, 4587 reported JPY 18.5B in revenue and (JPY 3.7B) in net income.
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 18.5B | JPY 46.7B | JPY 28.7B | JPY 26.9B | — |
| Gross Profit | JPY 7.5B | JPY 34.5B | JPY 17.2B | JPY 18.1B | — |
| Operating Income (EBIT) | (JPY 5.0B) | JPY 21.1B | JPY 6.8B | JPY 9.0B | — |
| Net Income | (JPY 3.7B) | JPY 15.0B | JPY 3.0B | JPY 7.6B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 77.0B | JPY 92.8B | JPY 69.5B | JPY 63.9B | — |
| Total Liabilities | JPY 25.5B | JPY 36.0B | JPY 29.1B | JPY 31.8B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4587 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms